IRIS
PONZONI, MAURILIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.732
EU - Europa 10.174
NA - Nord America 7.253
SA - Sud America 3.122
AF - Africa 238
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 3
Totale 31.546
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.866
RU - Federazione Russa 6.060
SG - Singapore 3.777
CN - Cina 3.168
BR - Brasile 2.542
HK - Hong Kong 1.489
SE - Svezia 1.181
VN - Vietnam 1.076
IT - Italia 911
FR - Francia 545
DE - Germania 416
BD - Bangladesh 325
GB - Regno Unito 265
AR - Argentina 237
FI - Finlandia 182
IN - India 177
CA - Canada 161
MX - Messico 138
AT - Austria 125
EC - Ecuador 111
ID - Indonesia 102
IE - Irlanda 102
JP - Giappone 101
NL - Olanda 77
IQ - Iraq 74
TR - Turchia 74
ZA - Sudafrica 71
ES - Italia 66
PL - Polonia 66
CO - Colombia 60
PY - Paraguay 51
MA - Marocco 47
CL - Cile 38
PK - Pakistan 36
SA - Arabia Saudita 36
VE - Venezuela 36
UA - Ucraina 35
UZ - Uzbekistan 27
KE - Kenya 26
MY - Malesia 25
TN - Tunisia 25
KR - Corea 23
PE - Perù 23
EG - Egitto 21
AE - Emirati Arabi Uniti 20
AU - Australia 20
IR - Iran 19
PT - Portogallo 19
PH - Filippine 17
LT - Lituania 16
JO - Giordania 15
BE - Belgio 14
DZ - Algeria 14
IL - Israele 13
JM - Giamaica 13
MD - Moldavia 13
OM - Oman 13
UY - Uruguay 13
LB - Libano 12
NP - Nepal 12
DO - Repubblica Dominicana 11
HN - Honduras 11
BO - Bolivia 10
KZ - Kazakistan 10
AZ - Azerbaigian 9
KW - Kuwait 9
PS - Palestinian Territory 9
TW - Taiwan 9
AL - Albania 8
CZ - Repubblica Ceca 8
GT - Guatemala 8
TT - Trinidad e Tobago 8
BB - Barbados 7
CH - Svizzera 7
CR - Costa Rica 7
CY - Cipro 7
ET - Etiopia 7
BH - Bahrain 6
BY - Bielorussia 6
CI - Costa d'Avorio 6
NI - Nicaragua 6
SY - Repubblica araba siriana 6
BG - Bulgaria 5
GG - Guernsey 5
HR - Croazia 5
HU - Ungheria 5
LV - Lettonia 5
NO - Norvegia 5
PA - Panama 5
RS - Serbia 5
SV - El Salvador 5
TH - Thailandia 5
YE - Yemen 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
GE - Georgia 4
KH - Cambogia 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
Totale 31.495
Salva come PNG Salva come JPEG
Città #
Dallas 1.628
Singapore 1.525
Hong Kong 1.478
Moscow 1.324
San Jose 838
Ashburn 829
Shanghai 596
Hefei 512
Lawrence 457
Princeton 457
Lauterbourg 440
Ho Chi Minh City 420
Beijing 339
New York 310
Milan 239
São Paulo 210
Hanoi 198
Los Angeles 155
Nuremberg 147
Helsinki 124
Santa Clara 121
Dublin 100
Rio de Janeiro 96
Munich 79
Boardman 75
Tokyo 68
Orem 67
Rome 65
Belo Horizonte 56
Vienna 56
Chennai 52
Biên Hòa 50
London 50
Warsaw 50
Brooklyn 49
Montreal 49
Brasília 41
Denver 41
Chicago 40
Guangzhou 40
Guayaquil 39
Poplar 39
Haiphong 38
Mexico City 38
Turku 38
Curitiba 37
The Dalles 37
Toronto 37
Atlanta 36
Da Nang 36
Houston 36
Johannesburg 36
Frankfurt am Main 35
Phoenix 34
Quito 34
Stockholm 34
Buffalo 33
Porto Alegre 33
Council Bluffs 30
Tianjin 29
Campinas 28
Salvador 28
Boston 27
Baghdad 26
Manchester 26
Seattle 26
Washington 26
Mumbai 25
Asunción 24
Dhaka 24
Jakarta 24
Nairobi 24
Naples 24
Sorocaba 24
Tashkent 23
Goiânia 22
Hangzhou 22
San Francisco 22
Shenzhen 22
Hải Dương 21
Osasco 21
Pune 21
Cesano Boscone 20
Columbus 20
Ankara 19
Bologna 19
Juiz de Fora 19
Ninh Bình 19
Thái Bình 19
Leicester 18
Amsterdam 17
Buenos Aires 17
Guarulhos 17
Querétaro 17
Santiago 17
Thái Nguyên 17
Joinville 16
Lappeenranta 16
Manaus 16
Charlotte 15
Totale 15.028
Salva come PNG Salva come JPEG
Nome #
Definition, diagnosis, and management of intravascular large B-Cell lymphoma: Proposals and perspectives from an international consensus meeting 335
Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma 254
3D-culture of CLL cells in bioreactor identifies the bone marrow as a key regulator of HS1 function in response to Ibrutinib 209
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination 197
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 193
[Clinical value of spleen autograft]. FT Considerazioni sul valore clinico dell'autoinnesto di milza 189
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 166
A multicenter study of treatment of primary CNS lymphoma 159
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 156
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 151
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 148
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial 147
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression 145
BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome 143
3D co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents 142
THREE-HOUR INFUSION OF METHOTREXATE AT 3 g/m2 SIGNIFICANTLY REDUCES CNS RELAPSES AND IMPROVES SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS AND INCREASED CNS RISK 139
CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF HIGH-GRADE B-CELL LYMPHOMAS TRANSFORMED FROM INDOLENT LYMPHOMAS IN HIV-NEGATIVE AND HIV-POSITIVE PATIENTS 137
A Mechanistic Role For Mir-126, a Hematopoietic Stem Cell Microrna, In Acute Leukemias 136
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 130
A MULTICENTER TRIAL ASSESSING FEASIBILITY AND EFFICACY OF A COMBINATION OF HIGH-DOSE METHOTREXATE, CYTARABINE AND THIOTEPA IN PATIENTS WITH PRIMARY CNS LYMPHOMA: IMPACT ON OUTCOME OF CYTARABINE DOSE 129
A PHASE II STUDY TO INVESTIGATE THE PREVALENCE OF INFECTIOUS AGENTS IN OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL) AND THE EFFICACY OF ANTIBIOTIC THERAPY (IELSG#27 TRIAL) 127
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy 126
A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL 125
A bitter effect: thrombocytopenia induced by a quinidine-containing beverage 124
A novel Rag2(-/-)gamma(-/-)(c)-xenograft model of human CLL 124
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 123
In vitro models of the crosstalk between multiple myeloma and stromal cells recapitulate the mild NF-κB activation observed in vivo 122
Follicular helper T cell signature of replicative exhaustion, apoptosis and senescence in common variable immunodeficiency 119
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 116
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.) 116
A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals 115
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 114
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 114
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 113
Central nervous system marginal zone B-cell lymphoma associated with chlamydophila psittaci infection 111
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial 111
SHORT-TERM DOSE-DENSE “CARMEN” THERAPY IS BETTER TOLERATED AND EVENLY EFFECTIVE THAN OTHER INTENSIFIED REGIMENS IN HIV- AND HIV+ PATIENTS WITH BURKITT LYMHOMA 110
A Six-Month Regimen of Oral Clarithromycin Is a Feasible and Active Therapy for Patients with Relapsed/Refractory Marginal Zone B-Cell Lymphoma of MALT-Type 110
A screening study of Chlamydia psittaci infection in 172 cases of nodal and extranodal non-hodgkin lymphomas 110
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 109
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 108
Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models 108
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models 107
Bone marrow as an alternative site for islet transplantation 106
A woman and her canary: a tale of chlamydiae and lymphomas 103
Anti-CD20 monoclonal antibody (Rituximab) in gastric extranodal marginal zone (MALT) non-Hodgkin's lymphoma (NHL) patients: Clinical and biological results (Phase II study). 102
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia 101
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation 101
A PHASE II TRIAL TO INVESTIGATE THE LINK WITH INFECTIOUS AGENTS IN OCULAR ADNEXAL MARGINAL ZONE LYMPHOMA, ESPECIALLY WITH CHLAMYDIA SPECIES, AND THE ANTINEOPLASTIC EFFECTS OF DOXYCYCLINE (IELSG#27) 101
Aggressive B-cell lymphoma with MYC/TP53 dual alterations displays distinct clinicopathobiological features and response to novel targeted agents 100
Chronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment 99
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 99
ORBIT IRRADIATION AS SALVAGE TREATMENT FOR PATIENTS WITH OCULAR ADNEXAL MALT LYMPHOMA (OAML) RELAPSED AFTER OR REFRACTORY TO CHLAMYDIA PSITTACI-ERADICATING ANTIBIOTIC THERAPY 98
DNA methylation alterations in prostate cancer: from diagnosis to treatment 98
Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects 97
Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells 97
Graft-versus leukemia effect of HLA-haploidentical central-memory T cells expanded with leukemic APCs and modified with a suicide gene 97
Autologous Pancreatic Islet Transplantation in Human Bone Marrow 96
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: Results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial 96
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming 95
Bone Marrow Histopathology in the Diagnostic Evaluation of Splenic Marginal-zone and Splenic Diffuse Red Pulp Small B-cell Lymphoma: A Reliable Substitute for Spleen Histopathology? 93
Activity of rituximab in extranodal marginal zone lymphomas (MALT-type). 93
The impact of histopathologic diagnosis on the proper management of testis neoplasms 92
A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma 92
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 92
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment 92
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine 92
T-N/SCM Pre-Selection Generates CAR T Cell Products Driving Superior Anti-Tumor Responses While Curtailing Severe CRS 91
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation 91
CD4+T cells sustain aggressive chronic lymphocytic leukemia in Em- TCL1 mice through a CD40L-independent mechanism 91
Primary central nervous system lymphoma 91
Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura 90
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis 90
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies 89
In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor 89
Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center 89
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study 89
Salvage Irradiation for Ocular Adnexal Mucosa Associated Lymphoid Tissue Lymphoma Refractory to Chlamydia psittaci Eradication 89
FEASIBILITY AND EFFICACY OF CHLAMYDIA PSITTACI ERADICATION WITH PROLONGED DOXYCYCLINE THERAPY IN LOCALIZED OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL): 7-YEAR RESULTS OF THE IELSG39 MULTICENTER TRIAL 88
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 88
Erratum: Autologous pancreatic islet transplantation in human bone marrow (Diabetes (2013) 62 (3523-3531)) 87
Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis 87
Plasma cells require autophagy for sustainable immunoglobulin production 86
Chlamydia infection and lymphoma: Multiple detection methods highlight an association beyond lymphomas of the ocular adnexa 86
Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL 86
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia 86
Kikuchi-Fujimoto Disease Shows Frequent T-Cell Antigen Loss and MUM1 Expression in Cytotoxic T Cells: a Multi-institutional Italian Study 85
Gene Expression Profiling Uncovers Molecular Classifiers for the Recognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell Neoplasms 85
Atypical presentation of Churg-Strauss syndrome or an undescribed hypereosinophilic disease? 84
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 84
Accelerated progression to AIDS in macaques coinfected with simian immunodeficiency virus and human herpesvirus 6A 84
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality 83
Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma 83
Subretinal lavage during diagnostic vitrectomy: an adjunctive technique for cell sampling in suspected vitreoretinal lymphoma 82
Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphoma 82
Modeling Multiple Myeloma-Bone Marrow interactions and response to drugs in a 3D surrogate microenvironment 81
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas 80
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications 79
Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma 79
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 79
Totale 11.232
Salva come PNG Salva come JPEG
Categoria #
all - tutte 208.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 208.509
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022303 0 0 2 146 11 12 26 41 10 15 7 33
2022/20232.400 1.054 461 121 10 21 278 117 164 90 27 22 35
2023/20241.220 70 66 97 129 118 223 63 92 32 57 67 206
2024/20256.419 796 102 90 181 169 500 737 513 1.234 1.092 485 520
2025/202621.420 1.425 1.979 2.109 3.201 1.288 548 1.666 1.464 5.516 1.055 630 539
Totale 31.926